Reporter Dec 16 2022
Dec. 19, 2022—BioVU, Vanderbilt University Medical Center’s biobank, has reached another milestone — deep-freeze storage of more than 300,000 biological samples.
Dec. 16, 2022—The new bivalent mRNA COVID-19 booster vaccines that began being used in September are beneficial in preventing COVID-19-associated hospitalization in persons 65 and over.
Dec. 16, 2022—by Bill Snyder Gordon Bernard, MD, a leader in clinical and translational medicine at Vanderbilt University Medical Center for more than 40 years, will step aside from his institutional leadership roles in July 2023 to focus more on his research interests and allow a new generation of leaders to take center stage. Bernard, the Melinda...
Dec. 15, 2022—The following is a roundup of the news that made headlines at Vanderbilt University Medical Center in 2022.
Dec. 15, 2022—New leadership appointments during the past year helped strengthen Vanderbilt University Medical Center's core missions.
Dec. 15, 2022—During the past year, Vanderbilt University Medical Center placed highly in several national rankings and was honored with numerous awards.
Dec. 15, 2022—Vanderbilt's Sara Van Driest, MD, PhD, has assumed a new post as the first-ever director of pediatrics for the National Institutes of Health’s All of Us Research Program, which aims to accelerate the prevention and treatment of illness through precision medicine.
Dec. 15, 2022—Vanderbilt investigators have discovered a molecular mechanism that promotes chronic kidney disease following kidney injury.
Dec. 15, 2022—An international team of investigators has found that mild to moderate reduction in kidney function may cause cardiovascular disease, even in people without symptoms of heart disease or diabetes.